Description: Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Home Page: coeptispharma.com
COEP Technical Analysis
105 Bradford Road
Wexford,
PA
15090
United States
Phone:
724 934 6467
Officers
| Name | Title |
|---|---|
| Mr. David Mehalick | Co-Founder, Chairman, CEO & Pres |
| Ms. Christine Elise Sheehy | Co-Founder, CFO & Sec. |
| Mr. Daniel Alexander Yerace | Co-Founder, VP of Operations & Director |
| Mr. Gary R. Conte | Sr. VP of Sales & Marketing |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 17.4238 |
| Price-to-Sales TTM: | 45.681 |
| IPO Date: | 2020-12-17 |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |